Sodium Valproate Suppliers & Bulk Manufacturers

Available Forms: Tablets / Oral suspension / Injection

Available Strengths: 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg,

Reference Brands: Depacon (USA), Convulex (EU), Valprol (India)

Category: Neurology

Sodium Valproate belongs to a group of medicines called anti-epileptics. It is used to treat two conditions – epilepsy and bipolar disorder. It also helps in the prevention of migraine. This way it prevents extreme mood swings and abnormal brain signals that trigger seizures (fits). Sodium Valproate is available in Tablets / Oral suspension / Injection and strengths such as 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg,. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sodium Valproate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Sodium Valproate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Valproate is a widely used medication available in multiple forms, including valproic acid, VPA, sodium valproate, and valproate semisodium. It is primarily prescribed for the prevention of migraine headaches, the treatment of epilepsy, and as a mood stabilizer in patients with bipolar disorder. Valproate is effective in managing various types of seizures, including absence seizures, partial seizures, and generalized seizures, helping to reduce the frequency and severity of these episodes.

The medication can be administered orally in tablet or syrup form, as well as intravenously for rapid therapeutic effect when needed. Oral formulations are available in both short-acting and long-acting versions, allowing for flexible dosing schedules tailored to patient needs. Valproate works by increasing levels of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain, which helps to calm excessive neuronal activity and prevent abnormal electrical discharges associated with seizures and mood disorders.

Its versatility, efficacy, and well-established clinical profile make valproate an essential treatment option in neurology and psychiatry for seizure control, migraine prevention, and mood stabilization.